JA
ABBV icon

JVL Associates’s AbbVie ABBV Stock Holding History

JVL Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$343K Buy
1,310
+130
+11% +$33.3K 0.1% 56
2026
Q2 		$297K Sell
1,180
-20
-2% -$4.3K 0.08% 59
2026
Q1 		$261K Buy
1,200
+54
+5% +$12K 0.09% 55
2025
Q4 		$262K Sell
1,146
-2
-0.2% -$456 0.09% 52
2025
Q3 		$266K Buy
1,148
+2
+0.2% +$407 0.09% 54
2025
Q2 		$213K Buy
1,146
+29
+3% +$5.39K 0.08% 63
2025
Q1 		$234K Sell
1,117
-48
-4% -$9.33K 0.09% 54
2024
Q4 		$207K Buy
1,165
+64
+6% +$11.8K 0.08% 55
2024
Q3 		$217K Buy
+1,101
New +$205K 0.08% 54

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

JVL Associates's ABBV Position: Q3 2026 in Review

JVL Associates increased its AbbVie (ABBV) stake by 11% in Q3 2026, buying an estimated $33.3K and bringing the position to 1,310 shares worth $343K. The position accounts for 0.1% of the portfolio, ranked #56.

JVL Associates first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • JVL Associates held 1,310 shares of AbbVie worth $343K as of Q3 2026.
  • JVL Associates bought 130 AbbVie shares in Q3 2026, an estimated $33.3K.
  • AbbVie made up 0.1% of JVL Associates's portfolio in Q3 2026, its #56 holding.
  • JVL Associates first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on JVL Associates's 13F filing for Q3 2026, filed 9 Oct 2026.